Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Market Cap	15.75B
Revenue (ttm)	5.16B
Net Income (ttm)	436.39M
Shares Out	1.22B
EPS (ttm)	0.36
PE Ratio	35.92
Forward PE	25.39
Dividend	0.10 (0.76%)
Ex-Dividend Date	May 29, 2025

Volume	6,302,398
Average Volume	12,905,749
Open	14.08
Previous Close	12.95
Day's Range	12.89 - 14.08
52-Week Range	9.98 - 16.66
Beta	0.73
RSI	29.08
Earnings Date	Oct 31, 2025

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2000
• Employees: 4,098
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002019